Overview

Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer

Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of doxorubicin and docetaxel followed by surgery in treating women who have stage II or stage III breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Case Comprehensive Cancer Center
Collaborator:
National Cancer Institute (NCI)
Treatments:
Cyclophosphamide
Docetaxel
Doxorubicin
Fluorouracil
Lenograstim
Liposomal doxorubicin
Methotrexate
Tamoxifen